Clal Biotechnology reported ILS46.74M in Market Capitalization this February of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Arca Biopharma USD 45M 339M Jun/2025
aTyr Pharma USD 60M 11M Feb/2026
Bio Path USD 3M 2M Jun/2025
Brainstorm Cell Therapeutics USD 29M 19M Jun/2025
Cara Therapeutics USD 46M 23M Jun/2025
Clal Biotechnology ILS 47.99M 4.37M Jan/2026
Compugen USD 137.5M 21.89M Sep/2025
Immunic USD 68M 2M Dec/2023
Infinity Pharmaceuticals USD 19M 5M Jun/2023
Minerva Neurosciences USD 43M 5M Dec/2023
RedHill Biopharma USD 12M 17M Jun/2024
TherapeuticsMD USD 24M 0 Mar/2024